1.46 (-%)
As of Jun 06, 2024
Source:
Avrobio, Inc is a clinical-stage gene therapy company with a purpose to free people from a lifetime of genetic disease. Our company is focused on developing potentially curative HSC gene therapies to treat patients with rare diseases following a single dose treatment regimen.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | 617.914.8420 |
Industry | manufacturing |
CEO | Erik Ostrowski |
Website | www.avrobio.com |